R&I Bulletin

July’s R&I Bulletin out now

July’s Research and Innovation Bulletin is available now here.

The top articles this month are:

  • Although non-Covid research was put on hold in March, our statistics show that we still exceeded our joint NCA target of 13,431 for the year 2019-20 with 18,425 participants involved in portfolio studies. Many thanks to all patients and staff involved.
  • Frailty is as important as either age or underlying health issues in determining whether someone may die from Covid-19, a new study has found. The analysis of 1,564 hospital patients at 11 sites – including Salford Royal – suggests increasing frailty is linked to a higher risk of death and longer time spent in hospital.
  • Well done to the Covid-19 research team at Salford Royal, who recruited the first UK patient to the SCIL-1Ra in Covid-19 study which aims to help critically ill patients on ventilators.
  • After a recent fire at The University of Manchester, R&I laboratory and governance staff have been working with colleagues from the University to provide emergency laboratory accommodation to a number of postgraduate and post-doctoral neuroscience colleagues so they could resume their critical experimental research within the Biomedical Facility at Salford Royal.
  • Eight new neuroscience research projects will soon get underway thanks to £62,000 funding through the Manchester Academic Health Science Centre Neuroscience Research Domain. The pilot projects will drive new research collaborations between Salford Royal, Manchester Centre for Clinical Neurosciences, The University of Manchester, Manchester Metropolitan University and Manchester University Hospitals Foundation Trust.

If you don’t currently get the monthly Bulletin but would like to do so, please email Claire.mooney@srft.nhs.uk